Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.

Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I.

JAMA. 1998 Aug 26;280(8):708-13.

PMID:
9728642
[PubMed - indexed for MEDLINE]
2.

A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.

Stein DJ, Berk M, Els C, Emsley RA, Gittelson L, Wilson D, Oakes R, Hunter B.

S Afr Med J. 1999 Apr;89(4):402-6.

PMID:
10341825
[PubMed - indexed for MEDLINE]
3.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
[PubMed - indexed for MEDLINE]
4.

Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study.

Stein DJ, Versiani M, Hair T, Kumar R.

Arch Gen Psychiatry. 2002 Dec;59(12):1111-8.

PMID:
12470127
[PubMed - indexed for MEDLINE]
5.

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

Stein MB, Chartier MJ, Hazen AL, Kroft CD, Chale RA, Coté D, Walker JR.

J Clin Psychopharmacol. 1996 Jun;16(3):218-22.

PMID:
8784653
[PubMed - indexed for MEDLINE]
6.

A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD.

J Clin Psychiatry. 2002 Jan;63(1):66-74.

PMID:
11838629
[PubMed - indexed for MEDLINE]
7.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
[PubMed - indexed for MEDLINE]
8.

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

Van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavallee YJ, Nandy S, Pecknold JC, Hadrava V, Swinson RP.

Am J Psychiatry. 2001 Feb;158(2):275-81.

PMID:
11156811
[PubMed - indexed for MEDLINE]
9.

The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder.

Stein DJ, Stein MB, Goodwin W, Kumar R, Hunter B.

Psychopharmacology (Berl). 2001 Nov;158(3):267-72.

PMID:
11713616
[PubMed - indexed for MEDLINE]
10.

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.

Baldwin D, Bobes J, Stein DJ, Scharwächter I, Faure M.

Br J Psychiatry. 1999 Aug;175:120-6.

PMID:
10627793
[PubMed - indexed for MEDLINE]
11.

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.

Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, Gee M, Davy K, Machin A.

Arch Gen Psychiatry. 2004 Nov;61(11):1153-62.

PMID:
15520363
[PubMed - indexed for MEDLINE]
12.

Controlled-release paroxetine in the treatment of patients with social anxiety disorder.

Lepola U, Bergtholdt B, St Lambert J, Davy KL, Ruggiero L.

J Clin Psychiatry. 2004 Feb;65(2):222-9.

PMID:
15003077
[PubMed - indexed for MEDLINE]
13.

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.

Allgulander C, Mangano R, Zhang J, Dahl AA, Lepola U, Sjödin I, Emilien G; SAD 388 Study Group.

Hum Psychopharmacol. 2004 Aug;19(6):387-96.

PMID:
15303242
[PubMed - indexed for MEDLINE]
14.

Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.

Stein MB, Sareen J, Hami S, Chao J.

Am J Psychiatry. 2001 Oct;158(10):1725-7.

PMID:
11579011
[PubMed - indexed for MEDLINE]
15.

Therapeutic advances: paroxetine for the treatment of social anxiety disorder.

Lydiard RB, Bobes J.

Depress Anxiety. 2000;11(3):99-104.

PMID:
10875050
[PubMed - indexed for MEDLINE]
16.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
17.

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.

Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.

Am J Psychiatry. 1999 May;156(5):756-60.

PMID:
10327910
[PubMed - indexed for MEDLINE]
18.

A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.

Rickels K, Mangano R, Khan A.

J Clin Psychopharmacol. 2004 Oct;24(5):488-96.

PMID:
15349004
[PubMed - indexed for MEDLINE]
19.

The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.

Hedges DW, Brown BL, Shwalb DA, Godfrey K, Larcher AM.

J Psychopharmacol. 2007 Jan;21(1):102-11. Epub 2006 May 19.

PMID:
16714326
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk